A detailed history of Cannell & Co. transactions in Pfizer Inc stock. As of the latest transaction made, Cannell & Co. holds 223,518 shares of PFE stock, worth $5.89 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
223,518
Previous 227,968 1.95%
Holding current value
$5.89 Million
Previous $7.56 Million 14.89%
% of portfolio
0.21%
Previous 0.27%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $116,278 - $151,033
-4,450 Reduced 1.95%
223,518 $6.44 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $45,728 - $53,451
-1,425 Reduced 0.62%
227,968 $7.56 Million
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $233,154 - $269,754
-6,455 Reduced 2.74%
229,393 $8.41 Million
Q1 2023

May 08, 2023

SELL
$39.39 - $51.28 $275,730 - $358,960
-7,000 Reduced 2.88%
235,848 $9.62 Million
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $79,158 - $103,332
-1,896 Reduced 0.77%
242,848 $12.4 Million
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $24,068 - $29,381
-550 Reduced 0.22%
244,744 $10.7 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $3,489 - $4,137
-75 Reduced 0.03%
245,294 $12.9 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $36,600 - $45,352
-800 Reduced 0.32%
245,369 $12.7 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $114,663 - $169,968
-2,775 Reduced 1.11%
246,169 $14.5 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $546,556 - $702,098
-13,925 Reduced 5.3%
248,944 $10.7 Million
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $777,990 - $881,332
-21,665 Reduced 7.61%
262,869 $10.3 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $280,311 - $316,134
-8,370 Reduced 2.86%
284,534 $10.3 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $6,694 - $8,512
200 Added 0.07%
292,904 $10.8 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $39,719 - $46,599
-1,251 Reduced 0.43%
292,704 $10.7 Million
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $209,635 - $254,318
-6,960 Reduced 2.31%
293,955 $9.61 Million
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $26,705 - $38,156
-988 Reduced 0.33%
300,915 $9.82 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $239,558 - $271,868
7,277 Added 2.47%
301,903 $11.8 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $66,604 - $86,366
2,050 Added 0.7%
294,626 $10.6 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $730,391 - $820,061
-19,751 Reduced 6.32%
292,576 $12.7 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $240,712 - $264,462
-6,419 Reduced 2.01%
312,327 $13.3 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $85,287 - $97,237
-2,217 Reduced 0.69%
318,746 $13.9 Million
Q3 2018

Nov 05, 2018

SELL
$34.47 - $41.81 $172,350 - $209,050
-5,000 Reduced 1.53%
320,963 $14.1 Million
Q2 2018

Aug 06, 2018

SELL
$32.98 - $35.16 $71,071 - $75,769
-2,155 Reduced 0.66%
325,963 $11.8 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $46,333 - $53,753
-1,452 Reduced 0.44%
328,118 $11.6 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $421,637 - $447,371
12,677 Added 4.0%
329,570 $11.9 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $9.82 Million - $10.8 Million
316,893
316,893 $11.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cannell & Co. Portfolio

Follow Cannell & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.